Aperture Therapeutics is a legitimate, verifiable preclinical biotechnology company founded in 2022 and based in San Carlos, CA. External search confirms they have secured NIH/NINDS grants and VC funding (Mission BioCapital, etc.) to develop oligonucleotide therapeutics for neurodegenerative diseases like ALS and FTD. However, the project submission itself is of extremely low quality, containing pseudonyms ('CrimsonFang') and demonstrably false claims regarding traction (claiming 'most people have used my product' while being in a preclinical stage with zero commercial users). While the real-world utility and technical innovation of the underlying company are high, the score is heavily penalized by the lack of current user utility and the inaccurate, unprofessional submission data.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline